FDA — authorised 4 October 2019
- Application: NDA211527
- Marketing authorisation holder: GALDERMA LABS LP
- Local brand name: AKLIEF
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Trifarotene cream in United States
FDA authorised Trifarotene cream on 4 October 2019
Marketing authorisation
Other Dermatology approved in United States
Frequently asked questions
Is Trifarotene cream approved in United States?
Yes. FDA authorised it on 4 October 2019.
Who is the marketing authorisation holder for Trifarotene cream in United States?
GALDERMA LABS LP holds the US marketing authorisation.